Baillie Gifford & Co
HCM icon

Baillie Gifford & Co’s HUTCHMED HCM Stock Holding History

Baillie Gifford & Co’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-144,969
Closed -$2.63M – 295
2023
Q4 		$2.63M Buy
144,969
+9,694
+7% +$176K ﹤0.01% 250
2023
Q3 		$2.29M Sell
135,275
-7,200
-5% -$103K ﹤0.01% 248
2023
Q2 		$1.71M Sell
142,475
-9,750
-6% -$133K ﹤0.01% 257
2023
Q1 		$1.98M Hold
152,225
– – ﹤0.01% 253
2022
Q4 		$2.25M Sell
152,225
-237,593
-61% -$2.6M ﹤0.01% 261
2022
Q3 		$3.45M Buy
389,818
+24,839
+7% +$313K ﹤0.01% 255
2022
Q2 		$4.61M Sell
364,979
-813
-0.2% -$10.4K ﹤0.01% 238
2022
Q1 		$6.92M Buy
365,792
+1,724
+0.5% +$43.9K ﹤0.01% 245
2021
Q4 		$12.8M Sell
364,068
-3,897
-1% -$127K 0.01% 239
2021
Q3 		$13.5M Buy
367,965
+707
+0.2% +$27.8K 0.01% 236
2021
Q2 		$14.4M Buy
367,258
+44,105
+14% +$1.27M 0.01% 236
2021
Q1 		$9.13M Buy
323,153
+29,130
+10% +$929K 0.01% 242
2020
Q4 		$9.41M Buy
294,023
+22,416
+8% +$689K 0.01% 221
2020
Q3 		$8.77M Buy
271,607
+44,567
+20% +$1.39M 0.01% 212
2020
Q2 		$6.26M Buy
227,040
+7,435
+3% +$161K ﹤0.01% 205
2020
Q1 		$3.92M Buy
219,605
+1,694
+0.8% +$40.9K ﹤0.01% 187
2019
Q4 		$5.46M Hold
217,911
– – 0.01% 185
2019
Q3 		$3.89M Hold
217,911
– – ﹤0.01% 195
2019
Q2 		$4.79M Sell
217,911
-2,985
-1% -$85.2K 0.01% 201
2019
Q1 		$6.75M Buy
220,896
+21,937
+11% +$547K 0.01% 194
2018
Q4 		$4.59M Buy
198,959
+1,213
+0.6% +$37.7K 0.01% 197
2018
Q3 		$6.37M Sell
197,746
-6,917
-3% -$211K 0.01% 197
2018
Q2 		$6.17M Sell
204,663
-1,477
-0.7% -$46.9K 0.01% 189
2018
Q1 		$6.09M Sell
206,140
-314
-0.2% -$11.2K 0.01% 188
2017
Q4 		$8.14M Buy
206,454
+20,850
+11% +$666K 0.01% 176
2017
Q3 		$5.06M Buy
185,604
+18,057
+11% +$443K 0.01% 183
2017
Q2 		$3.9M Buy
167,547
+9,655
+6% +$198K 0.01% 186
2017
Q1 		$3.15M Buy
157,892
+4,189
+3% +$62.9K ﹤0.01% 180
2016
Q4 		$2.09M Buy
153,703
+777
+0.5% +$9.93K ﹤0.01% 193
2016
Q3 		$1.83M Buy
152,926
+3,116
+2% +$39.8K ﹤0.01% 193
2016
Q2 		$1.97M Buy
+149,810
New +$1.98M ﹤0.01% 187

Other funds holding HCM

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Baillie Gifford & Co's HCM Position: Q1 2024 in Review

Baillie Gifford & Co sold out of HUTCHMED (HCM) in Q1 2024, closing a stake of 144,969 shares — an estimated $2.63M sold.

Baillie Gifford & Co first reported a position in HCM in Q2 2016 and held it in 31 quarters. The position peaked at $14.4M in Q2 2021. 71 funds tracked by Wall St. Rank hold HCM as of Q1 2024.

  • Baillie Gifford & Co reported no remaining HUTCHMED position as of Q1 2024 after selling out during the quarter.
  • Baillie Gifford & Co sold 144,969 HUTCHMED shares in Q1 2024, an estimated $2.63M.
  • Baillie Gifford & Co first reported a position in HUTCHMED in Q2 2016 and held it in 31 quarters.
  • Baillie Gifford & Co's HUTCHMED position peaked at $14.4M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2024.

Based on Baillie Gifford & Co's 13F filing for Q1 2024, filed 1 May 2024.